Ask AI
Bill115th CongressFiled May 7, 2018Health
H.R. 5686

Medicare Clear Health Options in Care for Enrollees Act of 2018

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary reported to house without amendment, part i (Jun 12, 2018)

Medicare Clear Health Options in Care for Enrollees Act of 2018 or the Medicare CHOICE Act of 2018

This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

What just happenedJun 12, 2018

Placed on the Union Calendar, Calendar No. 575.

Who’s behind it

Rep. Paulsen, Erik [R-MN-3](R-MN)Sponsor
6 cosponsors2 D4 R
Read on Congress.gov
6cosponsors2committees12actions2related bills5subjects
  1. Jun 12, 2018CalendarsH12410

    Placed on the Union Calendar, Calendar No. 575.

  2. Jun 12, 2018DischargeH12300

    Committee on Ways and Means discharged.

    Ways and Means Committee
  3. Jun 12, 2018Committee5500

    Committee on Ways and Means discharged.

    Ways and Means Committee
  4. Jun 12, 2018CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 115-741, Part I.

    Energy and Commerce Committee
  5. Jun 12, 2018Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 115-741, Part I.

    Energy and Commerce Committee
  6. May 16, 2018Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  7. May 9, 2018Committee

    Ordered to be Reported by Voice Vote.

    Energy and Commerce Committee
  8. May 9, 2018Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  9. May 7, 2018IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Ways and Means Committee
  10. May 7, 2018IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  11. May 7, 2018IntroReferralIntro-H

    Introduced in House

  12. May 7, 2018IntroReferral1000

    Introduced in House

Reported to House without amendment, Part IJun 12, 201828

Medicare Clear Health Options in Care for Enrollees Act of 2018 or the Medicare CHOICE Act of 2018

This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

Introduced in HouseMay 7, 2018

Medicare Clear Health Options in Care for Enrollees Act of 2018 or the Medicare CHOICE Act of 2018

This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

Medicare Clear Health Options in Care for Enrollees Act of 2018 — Informed